Bellevue Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,000
| Closed | -$253K | – | 173 |
|
|
2024
Q1 | $253K | Buy |
+12,000
| New | +$253K | ﹤0.01% | 151 |
|
|
2020
Q3 | – | Sell |
-41,000
| Closed | -$1.51M | – | 221 |
|
|
2020
Q2 | $1.51M | Buy |
41,000
+4,100
| +11% | +$151K | 0.02% | 140 |
|
|
2020
Q1 | $1.2M | Buy |
36,900
+16,000
| +77% | +$518K | 0.02% | 140 |
|
|
2019
Q4 | $856K | Sell |
20,900
-12,800
| -38% | -$524K | 0.01% | 151 |
|
|
2019
Q3 | $1.2M | Buy |
33,700
+600
| +2% | +$21.4K | 0.02% | 138 |
|
|
2019
Q2 | $1.7M | Hold |
33,100
| – | – | 0.03% | 134 |
|
|
2019
Q1 | $1.9M | Buy |
33,100
+9,800
| +42% | +$562K | 0.1% | 111 |
|
|
2018
Q4 | $977K | Hold |
23,300
| – | – | 0.06% | 115 |
|
|
2018
Q3 | $1.76M | Sell |
23,300
-500
| -2% | -$37.7K | 0.11% | 107 |
|
|
2018
Q2 | $1.71M | Buy |
+23,800
| New | +$1.71M | 0.15% | 94 |
|